AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00326872

Locations


United States, Alabama
	Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham	Recruiting
	Birmingham, Alabama, United States, 35294
	Contact: Clinical Trials Office - Lurleen Wallace Comprehensive Cancer 205-934-0309

United States, District of Columbia
	Howard University Cancer Center	Recruiting
	Washington, District of Columbia, United States, 20060
	Contact: Clinical Trials Office - Howard University Cancer Center 202-806-9122

United States, Illinois
	University of Chicago Cancer Research Center	Recruiting
	Chicago, Illinois, United States, 60637-1470
	Contact: Clinical Trials Office - University of Chicago Cancer Research 773-834-7424

United States, Massachusetts
	Massachusetts General Hospital	Recruiting
	Boston, Massachusetts, United States, 02114
	Contact: Clinical Trials Office - Massachusetts General Hospital 877-726-5130

United States, Michigan
	Barbara Ann Karmanos Cancer Institute	Recruiting
	Detroit, Michigan, United States, 48201-1379
	Contact: Clinical Trials Office - Barbara Ann Karmanos Cancer Institute 313-576-9363

United States, Minnesota
	Mayo Clinic Cancer Center	Recruiting
	Rochester, Minnesota, United States, 55905
	Contact: Clinical Trials Office - All Mayo Clinic Locations 507-538-7623

United States, Missouri
	Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis	Recruiting
	Saint Louis, Missouri, United States, 63110-4803
	Contact: Gerald P. Linette, MD, PhD 314-747-7222

United States, Ohio
	Case Comprehensive Cancer Center	Recruiting
	Cleveland, Ohio, United States, 44106-5065
	Contact: Clinical Trials Office - Case Comprehensive Cancer Center 800-641-2422

Sponsors and Collaborators

Mayo Clinic

National Cancer Institute (NCI)

Investigators


Study Chair:	Dusica Babovic-Vuksanovic, MD	Mayo Clinic